Air Freight for Pharmaceutical Exports from India: Handling and Compliance

Air Freight for Pharmaceutical Exports from India requires far more control than a standard international cargo movement because pharmaceutical quality can be affected by time, temperature, handling, documentation and route disruptions. For a manufacturer, the shipment is not complete simply when the cargo reaches the destination airport. The product must arrive within its approved transport conditions, with complete documentation and without an unacceptable temperature excursion.

India’s pharmaceutical exports reached approximately US$31.11 billion in FY2025-26, reflecting the scale at which Indian manufacturers supply formulations, APIs, vaccines, biological products and specialised medicines to international markets. In FY2024-25, formulations and biologicals alone contributed approximately US$22.93 billion, representing more than 75% of India’s pharmaceutical exports.

The United States remains one of the most important destinations for Indian pharmaceutical companies. Indian pharmaceutical exports to the US were approximately US$10.52 billion in FY2024-25, accounting for around 34.51% of total pharmaceutical export value. Europe is another important market, particularly for manufacturers supplying regulated healthcare markets.

These numbers make logistics reliability commercially important. A pharmaceutical consignment worth ₹20 lakh, ₹50 lakh or ₹1 crore cannot be handled with the same level of risk as ordinary cargo. A delayed general cargo shipment may create storage charges. A delayed pharmaceutical shipment can create storage charges, packaging concerns, temperature deviation investigations, QA review and potentially rejection of the complete shipment.

Pharmaceutical exporters therefore need to evaluate air freight on 5 important parameters – product temperature requirement, packaging duration, route reliability, regulatory readiness and total logistics cost.

Air Freight for Pharmaceutical Exports from India – Quick Answer

Air freight is commonly selected for pharmaceutical exports when the shipment is high-value, temperature-sensitive, urgent, shelf-life sensitive or required quickly by an overseas buyer. The complete movement normally includes manufacturing release, qualified packaging, temperature-controlled pickup where required, airport handling, export customs clearance, airline acceptance, controlled storage, aircraft loading, international transit, destination handling and final delivery.

The required temperature range depends on the actual pharmaceutical product. Many medicines may move under 15°C to 25°C controlled room temperature conditions, while other products require 2°C to 8°C refrigerated handling. Frozen pharmaceutical cargo may require approximately -20°C or below, while certain advanced therapies and specialised biological products can require much lower temperatures.

Air freight planning should begin with the manufacturer’s approved product transport specification. The logistics provider should not assume that every vaccine requires the same temperature or that every finished formulation can move under ambient conditions.

Official Indian customs time-release data provides a useful operational benchmark. Average export regulatory clearance at Indian Air Cargo Complexes has been approximately 3 hours 58 minutes from cargo arrival to Let Export Order. Refrigerated export cargo has recorded an average arrival-to-departure time of approximately 21 hours 38 minutes.

This means customs processing may not always be the biggest source of delay. A shipment can complete customs clearance and still face additional waiting because of airline cut-offs, flight schedules, cold-room dwell, ramp movement or connection delays.

For pharmaceutical exporters, the correct decision is therefore based on temperature integrity, compliance, route reliability, packaging duration and total cost, not simply the lowest air freight rate.

Why Pharmaceutical Exports Need Specialised Air Freight Planning

A pharmaceutical shipment contains much more operational risk than an ordinary box moving from one airport to another.

Consider a manufacturer in Hyderabad exporting 750 kg of 2°C to 8°C pharmaceutical cargo to a European customer. The batch has been released by quality assurance, the commercial invoice is ready and airline space has been booked.

At first glance, the shipment appears ready to move.

In practice, several things can still go wrong before departure.

The refrigerated vehicle may arrive late at the manufacturing unit. The cargo may reach the airport close to the airline acceptance deadline. Customs may request clarification. A document may show the wrong package count. The scheduled aircraft may change. The flight may be delayed by 8 hours. The cargo may remain in the airport cold room longer than expected.

Each additional hour matters because temperature-controlled packaging has a qualified duration.

Suppose a passive packaging system is qualified for 96 hours and the expected door-to-door movement is 60 hours. The exporter has approximately 36 hours of additional qualified time available for normal disruption.

If the flight is delayed by 6 hours, the shipment may still remain comfortably within the planned window.

If the flight is cancelled for 30 hours and the destination connection is also delayed, that safety margin can reduce quickly.

This is why pharmaceutical freight planning should not be based only on the expected schedule. It should also consider what happens when the expected schedule fails.

A strong pharmaceutical logistics plan therefore considers both the normal route and the contingency route before cargo leaves the manufacturing facility.

India’s Pharmaceutical Export Market and Why Logistics Matters

India’s pharmaceutical industry exports to more than 190 countries and serves both developing markets and highly regulated healthcare systems.

Pharmaceutical exports crossed approximately US$31 billion in FY2025-26, while pharmaceutical exports during FY2024-25 were approximately US$30.47 billion, representing growth of around 9.40%.

Finished formulations and biological products represented approximately US$22.93 billion, or around 75.26% of the country’s pharmaceutical exports in FY2024-25.

Bulk drugs and drug intermediates contributed approximately US$4.87 billion, while vaccines contributed around US$1.22 billion.

This product mix matters from a freight perspective because many formulations, biological products and vaccines have a high value relative to their weight.

A 300 kg pharmaceutical shipment can therefore carry significantly more commercial value than several tonnes of ordinary industrial cargo.

Air freight becomes commercially important because the exporter is not only buying speed. The exporter may also be reducing inventory exposure, protecting remaining shelf life and helping the buyer avoid stock shortages.

Suppose a pharmaceutical shipment has 90 days of usable commercial shelf life remaining.

If sea transportation and related logistics consume 35 days, approximately 39% of the remaining period is already used before the cargo becomes available to the buyer.

If air freight reduces the complete movement to 5 days, only around 6% of that 90-day period is consumed in logistics.

For certain products, that difference can justify a much higher freight cost.

Which Pharmaceutical Products Commonly Move by Air?

Air freight is usually preferred when speed, product value or cargo sensitivity makes longer transit commercially unattractive.

Finished formulations are commonly moved by air when buyers need rapid replenishment or when delivery commitments are tight.

Vaccines and biological products may also move by air because temperature control and transit duration can be critical.

APIs can move by air when manufacturing operations at the destination depend on urgent replenishment.

Clinical materials, diagnostic products and specialised healthcare supplies are another category where air transportation is often preferred.

Emergency medicine shipments and replacement cargo may also require premium air movement because the cost of waiting is significantly greater than the freight difference.

Consider a shipment worth ₹40 lakh with a gross weight of only 500 kg.

If air freight costs ₹3 lakh more than a slower alternative but reduces transit by 20 days, the decision should not be based only on the ₹3 lakh premium.

The exporter should consider the value of faster customer delivery, lower inventory in transit, reduced shelf-life consumption and lower disruption risk.

Products commonly moved by pharmaceutical air freight include:

• Finished formulations and medicines
• Vaccines and biological products
• APIs and production-critical material
• Clinical and specialised healthcare products

Air freight should still be selected based on actual commercial and quality requirements rather than using a single rule for every pharmaceutical product.

Temperature Requirements for Pharmaceutical Air Cargo

Temperature management is one of the most important parts of Pharma Export Logistics in India.

The freight forwarder should begin by asking for the manufacturer’s approved transportation condition.

A product requiring 15°C to 25°C should not be treated as normal ambient cargo simply because refrigeration is not required.

During Indian summer conditions, road vehicles, airport loading zones and ramp areas can experience temperatures well above the product’s upper limit.

This means a 15°C to 25°C shipment may still require insulated packaging, controlled transport, thermal protection and careful airport handling.

Products requiring 2°C to 8°C need even tighter control.

These shipments may require refrigerated vehicles, cold-room storage, validated packaging, active containers or passive packaging systems and temperature-monitoring devices.

Frozen cargo may require approximately -20°C or below.

Certain specialised therapies can require approximately -70°C or lower, which demands specialised packaging, dry ice management or dedicated active solutions.

The challenge is that temperature must remain within the approved range across every logistics handover.

Factory storage can be perfect.

The refrigerated vehicle can maintain the correct temperature.

The airport cold room can also maintain the correct temperature.

But if cargo then remains outside for 45 minutes during aircraft loading under uncontrolled conditions, the complete shipment may still require investigation.

The correct approach is therefore to map the complete cold chain from factory to consignee.

Handling Category	Typical Temperature Range	Main Logistics Risk
Controlled Room Temperature	15°C to 25°C	Heat exposure and uncontrolled dwell
Refrigerated	2°C to 8°C	Temperature excursion during transfer
Frozen	Around -20°C or below	Packaging duration and storage availability
Deep Frozen	Around -70°C or below	Specialised equipment and handling

These temperature ranges are operational examples. The manufacturer’s validated product requirement should always remain the final reference.

Step-by-Step Pharmaceutical Air Freight Export Process

Pharmaceutical export logistics begins before freight is booked.

The first stage is product and shipment assessment.

The exporter confirms product name, batch, shipment weight, dimensions, required temperature, pickup location, destination and requested delivery date.

The second stage is route planning.

The freight forwarder compares direct and connecting flight options, airport capability, handling infrastructure, departure frequency and expected transit time.

For a ₹10 lakh stable medicine shipment, a connecting service may be commercially reasonable.

For a ₹1 crore biological consignment requiring 2°C to 8°C control, the exporter may prefer a more expensive direct route with fewer handovers.

The third stage is packaging planning.

The packaging configuration should be appropriate for the required temperature and expected journey duration.

A 60-hour movement should ideally not depend on packaging qualified for exactly 60 hours.

The shipper should allow for reasonable delay and disruption.

The fourth stage is booking.

The freight forwarder confirms airline space, flight routing and cargo acceptance requirements.

The fifth stage is manufacturing pickup.

The cargo is collected after commercial and quality release.

Where temperature control is required, the pickup vehicle should maintain the approved condition.

The sixth stage is airport entry.

Cargo reaches the export terminal, where shipment documents, labels, weight, dimensions and physical condition may be checked.

The seventh stage is customs processing.

The Shipping Bill is filed and customs processes the declaration through the electronic system.

Some cargo may be facilitated quickly, while other shipments can require assessment or examination depending on risk parameters and applicable regulatory requirements.

After customs requirements are completed, Let Export Order is issued.

The eighth stage is airline acceptance and controlled storage.

The cargo remains inside the appropriate handling environment while waiting for aircraft loading.

The ninth stage is airside transfer.

For temperature-sensitive cargo, this handover can be one of the most important critical control points.

The tenth stage is international movement.

The shipment either moves directly to the destination or passes through a connecting airport.

The final stage includes destination cargo handling, import clearance and final delivery according to the agreed logistics scope.

Pharmaceutical Air Freight Process

Stage	Main Party	Typical Time	Main Requirement	Main Risk
Product release	Manufacturer / QA	Internal	Batch release	Cargo not commercially ready
Route planning	Exporter + Forwarder	1-2 days	Shipment data	Wrong routing
Packaging	Shipper	Hours	Qualified packaging	Insufficient duration
Factory pickup	Transporter	Same day	Temperature control	Excursion
Airport acceptance	Terminal / Airline	Hours	AWB and cargo documents	Rejection
Customs filing	Exporter / Broker	Hours	Shipping Bill	Data mismatch
Customs processing	Customs	Often within hours	Supporting documents	Query or examination
Airport storage	Handler	Hours	Correct temperature	Extended dwell
Aircraft loading	Airline / Handler	Before departure	Flight acceptance	Missed uplift
International transit	Airline	Hours to days	AWB	Connection delay
Destination delivery	Overseas logistics partner	1-2 days	Import documents	Last-mile excursion

The most reliable shipments are those where each stage has been planned as part of one continuous logistics process.

Active vs Passive Packaging for Pharmaceutical Air Freight

Packaging is not simply a box around the product.

For pharmaceutical cargo, it is part of the temperature-control system.

Passive packaging uses insulated materials combined with refrigerants or phase-change materials to maintain the required internal temperature for a validated duration.

The advantage is that passive systems generally do not require continuous external power.

They can be effective for many pharmaceutical routes when properly qualified.

The main limitation is time.

Suppose a passive packaging solution is qualified for 72 hours.

The planned transport cycle is 52 hours.

This provides approximately 20 hours of additional protection.

If a flight connection adds 4 hours, there may be no operational concern.

If a cancellation creates a 24-hour delay, the shipment may move beyond the qualified duration.

Active containers use powered or mechanically controlled systems to maintain the internal environment.

These can be useful for high-value, large-volume or particularly sensitive cargo.

They generally involve higher rental cost, equipment planning and airline coordination.

The correct decision depends on the value of the cargo and the consequence of failure.

Suppose passive packaging costs ₹80,000 while an active solution costs ₹2 lakh.

For cargo worth ₹5 lakh, the active solution may be commercially difficult to justify.

For cargo worth ₹2 crore, paying an additional ₹1.20 lakh for stronger environmental control may represent less than 0.1% of cargo value.

That is why packaging cost should always be evaluated relative to product value and risk.

Exporters should consider:

• Product temperature and cargo value
• Expected route duration
• Number of handling points
• Cost of a temperature excursion

Pharmaceutical Export Documentation and Compliance

Documentation can delay pharmaceutical cargo even when the physical shipment has been prepared perfectly.

The core commercial documents usually include the Commercial Invoice, Packing List, Shipping Bill and Airway Bill.

Additional documents depend on the product, destination market and transaction structure.

A Certificate of Origin may be required for certain trade arrangements or buyer requirements.

Product-specific regulatory certificates, licences or approvals may apply depending on the pharmaceutical product and purpose of export.

Insurance documents may also be required.

Temperature-sensitive shipments can include handling instructions, packaging details, temperature-monitoring records and other quality documentation based on the shipper’s internal process and buyer requirements.

The biggest operational risk is inconsistency between documents.

Suppose the Commercial Invoice shows 100 cartons, the Packing List shows 98 cartons and the Shipping Bill records 100 packages.

This type of discrepancy may require correction.

A similar problem can occur when one document shows a gross weight of 620 kg while another shows 650 kg.

A difference of only 30 kg may appear minor at the factory, but once the shipment enters customs and airline systems, amendments can take time.

For pharmaceutical shipments, documentation should therefore be checked before cargo pickup rather than after airport arrival.

Pharmaceutical Export Documentation

Document	Prepared / Issued By	Purpose	Main Risk
Commercial Invoice	Exporter	Commercial details and value	Description or value mismatch
Packing List	Exporter	Package and weight details	Cargo mismatch
Shipping Bill	Exporter / Customs Broker	Export customs declaration	Customs delay
Airway Bill	Airline / Freight Forwarder	Air transport document	Routing or consignee error
Certificate of Origin	Authorised body where applicable	Origin evidence	Buyer or tariff issue
Regulatory Documents	Relevant authority where applicable	Product compliance	Cargo hold
Insurance Certificate	Insurer	Cargo protection	Claim difficulty
Temperature Instructions	Manufacturer	Handling condition	Incorrect handling

A simple pre-shipment document review can prevent hours of correction later.

Customs Clearance for Pharmaceutical Air Cargo from India

Export customs clearance for pharmaceutical cargo follows the Indian electronic export declaration process, although product-specific requirements can increase complexity.

The Shipping Bill contains exporter information, IEC, commodity classification, destination, cargo quantity, value, package information and other details.

The declaration is processed electronically through Indian Customs.

Customs uses risk-based processing.

This means every pharmaceutical export shipment is not physically examined.

Some shipments can move through the system quickly while others may be selected for additional assessment or examination.

For this reason, a universal claim that 10% or 20% of pharma exports are inspected should not be used.

Inspection depends on product, documentation, risk profile and applicable regulatory controls.

Official time-release data provides a much stronger number.

Average export regulatory clearance at Air Cargo Complexes has been approximately 3 hours 58 minutes.

However, exporters should not assume that every pharmaceutical shipment will clear within 4 hours.

A customs query, incorrect HS Code, missing supporting document or regulatory issue can extend the process.

For practical planning, businesses may maintain a 24 to 72-hour operational contingency where additional regulatory intervention is possible, but this should be treated as a planning buffer rather than the official customs average.

The best risk-control measure is accurate documentation before airport entry.

Refrigerated Air Cargo Can Move Faster Than General Cargo

Temperature-controlled freight is often assumed to be slow because it involves specialised procedures.

Indian air cargo data shows that this is not always correct.

Average arrival-to-departure time for refrigerated export cargo at Air Cargo Complexes has been approximately 21 hours 38 minutes.

For non-refrigerated export cargo, the corresponding figure has been approximately 35 hours 48 minutes.

The difference is more than 14 hours.

This suggests that specialised handling and priority processes can support fast cargo movement when the shipment has been properly prepared.

For pharmaceutical exporters, this has an important implication.

Cold-chain requirements should not be treated as obstacles that must be avoided.

They should be treated as operational requirements that need to be built into the freight plan.

If cargo arrives with complete documents, qualified packaging and confirmed airline space, specialised handling can remain efficient.

The problem usually begins when temperature-sensitive cargo enters the airport before documentation or flight planning is complete.

Hyderabad as a Pharmaceutical Air Cargo Gateway

Hyderabad is one of India’s most important pharmaceutical manufacturing and air cargo locations.

Pharmaceutical shipments account for approximately 72% of Hyderabad Airport’s export cargo.

This means nearly 3 out of every 4 units in the airport’s stated export cargo mix are linked to the pharmaceutical sector.

Hyderabad Airport handled approximately 180,914 metric tonnes of cargo during CY2024, while international cargo reached around 108,520 tonnes.

The concentration of pharmaceutical manufacturing around Hyderabad makes proximity to specialised airport infrastructure particularly valuable.

Shorter road movement between the manufacturing facility and airport can reduce the amount of time cargo spends outside a controlled terminal environment.

Hyderabad strengthened this infrastructure further in 2026 with Cargo Terminal 2.

The facility covers approximately 16,864 square metres.

Its initial cargo handling capacity is approximately 50,000 metric tonnes annually, with the ability to expand to around 100,000 metric tonnes.

The terminal includes specialised temperature-controlled infrastructure for pharmaceutical and other sensitive cargo.

Customs time-release data also provides an interesting operational benchmark.

At Hyderabad, average export movement from cargo arrival to Let Export Order has been approximately 1 hour 16 minutes.

Average cargo arrival-to-departure time has been approximately 22 hours 17 minutes.

These are historical averages rather than guaranteed service times.

However, they demonstrate why Hyderabad should be treated as more than simply a manufacturing centre.

It is also an important pharmaceutical logistics gateway.

Airside Temperature Risk – Why the Airport Ramp Matters

Many exporters focus heavily on factory refrigeration and airport cold rooms.

The movement between the cold room and aircraft often receives less attention.

This can be one of the most exposed parts of the shipment.

Suppose a 2°C to 8°C shipment remains inside a controlled airport facility for 18 hours.

The temperature remains completely stable.

The cargo is then transferred toward the aircraft.

If this movement exposes the shipment to uncontrolled heat for 30 to 45 minutes, the temperature logger may still record an excursion depending on packaging performance and external conditions.

Hyderabad Airport introduced a dedicated airside refrigerated vehicle in 2026 capable of maintaining approximately +2°C to +25°C.

The vehicle has payload capacity of around 10 tonnes and incorporates temperature and humidity monitoring.

This is important because a pharmaceutical cold chain should include every handover, not just the warehouse sections.

The operational question should therefore not only be:

“Does the airport have a cold room?”

Exporters should also understand how cargo moves from the cold room to the aircraft and how long that movement normally takes.

A strong freight plan maps every point where temperature control changes hands.

Bengaluru, Delhi and Mumbai for Pharmaceutical Air Cargo

Hyderabad is particularly strong for pharmaceutical exports, but other Indian air cargo gateways remain important.

Bengaluru Airport has cargo handling capacity of approximately 715,000 metric tonnes per year.

Its pharmaceutical and temperature-sensitive cargo infrastructure makes it relevant for manufacturers across Karnataka and South India.

Its international network can connect pharmaceutical cargo with major hubs across Europe, North America, the Middle East and Asia.

Delhi is strategically important for pharmaceutical manufacturers located across Delhi NCR, Haryana, Punjab, Uttarakhand and parts of North India.

For these exporters, using Delhi can reduce long inland transportation before the flight.

Mumbai remains another major pharmaceutical logistics gateway because of its airline connectivity and proximity to pharmaceutical clusters in Maharashtra and western India.

Airport selection should not be based only on distance.

Consider 2 options.

Airport A is 150 km from the factory but the shipment requires 2 international connections.

Airport B is 300 km away but provides a direct flight.

For ordinary cargo, Airport A may appear more convenient.

For a ₹1 crore biological shipment, Airport B could offer lower overall risk because fewer air transfers may compensate for the additional controlled road distance.

The right airport decision should consider:

• Refrigerated inland distance
• Airline frequency and direct connectivity
• Cold-chain capability
• Route and connection risk

What Determines Pharmaceutical Air Freight Cost?

Pharmaceutical air freight cost includes much more than the airline freight rate.

A typical quotation can contain multiple operational components.

The first component is temperature-controlled pickup.

If the product requires 2°C to 8°C conditions, a refrigerated vehicle may be required from the manufacturing unit to the airport.

The second cost is qualified packaging.

Passive systems can include insulated packaging, refrigerants and phase-change materials.

Active containers can create a significantly higher cost but may provide stronger control for selected shipments.

The third cost is airline freight.

Air freight is normally calculated using chargeable weight.

Suppose a pharma shipment physically weighs 500 kg but its volumetric weight is 720 kg.

The airline may charge the freight based on 720 kg.

At an illustrative freight rate of ₹300 per kg, this difference represents:

220 kg x ₹300 = ₹66,000

of additional freight cost created by shipment volume rather than physical weight.

The fourth component is airport terminal handling.

At Hyderabad, a published pharma export processing tariff provides an example of approximately ₹5.08 per kg, subject to applicable terms and minimums.

Frozen pharmaceutical cargo up to approximately -20°C has carried a higher published terminal processing example of around ₹6.10 per kg.

The fifth component is airport storage.

Specialised pharmaceutical storage can be charged according to weight and duration.

The sixth component can include airside temperature-controlled transfer.

The seventh component is monitoring.

Data loggers and specialised tracking systems can add cost.

The eighth component is destination handling and temperature-controlled final delivery.

This is why the correct comparison is not:

“Which forwarder has the cheapest airline rate?”

The better question is:

“What will the complete pharmaceutical shipment cost from factory pickup to final delivery?”

Real Airport Delay Cost Example

Consider a 1,500 kg pharmaceutical shipment that becomes chargeable for 2 additional airport storage days.

Using an illustrative calculation based on a published pharma export storage example of approximately ₹5.08 per kg per day:

1,500 kg x ₹5.08 x 2 days = ₹15,240

This is only the airport storage component.

Suppose the shipment then requires another temperature-controlled vehicle movement costing an illustrative ₹20,000.

Packaging intervention costs another ₹30,000.

The airline’s replacement booking creates an additional ₹40,000 rate difference.

The combined operational impact becomes approximately:

₹15,240 + ₹20,000 + ₹30,000 + ₹40,000 = ₹1,05,240

This scenario demonstrates why a one or 2-day delay can cost much more than the airport storage invoice alone.

The larger concern may still be product integrity.

If the packaging qualification has expired, the exporter could face a much bigger commercial risk than ₹1 lakh of logistics costs.

Direct Flights vs Connecting Flights for Pharmaceutical Exports

Direct flights can reduce several important pharmaceutical logistics risks.

Every connection introduces another airport, ground handler, warehouse, ramp movement and timing dependency.

A connecting service can still be suitable when the airline and transit hub have strong pharmaceutical handling processes.

However, the freight rate should not be the only selection factor.

Consider a ₹75 lakh refrigerated shipment.

Route A costs ₹3.5 lakh and moves direct.

Route B costs ₹3.1 lakh but requires a 10-hour international connection.

The exporter saves ₹40,000 with Route B.

The saving is approximately 0.53% of the ₹75 lakh cargo value.

If the additional connection creates meaningful temperature or delay risk, the ₹40,000 saving may not be commercially attractive.

Now consider a ₹4 lakh controlled room temperature shipment with strong stability data.

The same ₹40,000 saving represents 10% of cargo value.

In that case, the connecting route may be worth evaluating more closely.

The correct choice therefore depends on risk-adjusted cost rather than route price alone.

Major Risks in Pharmaceutical Air Freight

Temperature Excursion

Temperature excursion is one of the most important operational risks in pharmaceutical transportation.

An excursion does not always mean the product must be destroyed.

However, it can require the manufacturer’s quality team to review the actual temperature, duration of exposure and available stability data.

This creates uncertainty at destination.

If the buyer cannot release the product until the investigation is complete, a shipment that physically arrived on time may still become commercially delayed.

The safest approach is to reduce the number and duration of uncontrolled handling points.

Customs Hold

A customs query can create additional airport dwell.

For standard cargo, the primary concern may be storage cost.

For pharma cargo, the exporter also needs to consider whether packaging and temperature control can safely cover the delay.

A 24-hour customs delay can therefore have a very different impact on a general industrial part and a refrigerated biologic.

Wrong HS Code

Incorrect HS classification can create customs processing problems and potentially affect regulatory requirements.

HS Code verification should happen before Shipping Bill filing.

This is particularly important when exporting a new pharmaceutical product for the first time.

Documentation Mismatch

A mismatch in quantity, package count, product description or consignee details can require amendments.

A 20-minute internal document review can prevent several hours of airport coordination.

Airline Cut-Off

Confirmed airline space does not guarantee uplift.

Cargo still needs to meet airline acceptance deadlines.

A shipment reaching the terminal 2 hours late can miss the planned flight.

For a route with only 1 suitable flight per day, this can immediately create a 24-hour delay.

Flight Cancellation

Aircraft schedules can change because of weather, technical issues or network disruptions.

For pharma exporters, the question is not whether flight cancellations can happen.

The question is whether the packaging and logistics plan can absorb the delay when they do happen.

What Happens When the Pharmaceutical Cold Chain Breaks?

Consider a hypothetical shipment worth ₹25 lakh that must remain between 2°C and 8°C.

The shipment moves through the airport and departs as planned.

During an international connection, the temperature logger records an extended period outside the accepted range.

The consignee receives the cargo but cannot immediately release it.

The manufacturer’s quality team must evaluate the temperature profile.

If stability data supports the excursion, the shipment may eventually be accepted.

If the exposure falls outside the approved stability position, replacement may be required.

Suppose the original product value is ₹25 lakh.

Replacement production requires another ₹25 lakh worth of goods.

New validated packaging and air freight add an illustrative ₹3 lakh.

The direct commercial exposure can reach approximately ₹28 lakh beyond the original shipment already at risk.

If the customer also experiences a stock shortage, the broader impact can be even greater.

Compare this with saving ₹30,000 or ₹50,000 on a cheaper route.

This is why pharmaceutical logistics must be evaluated according to the financial consequence of failure.

1. 2°C to 8°C Shipment from Hyderabad to Europe

A Hyderabad pharmaceutical manufacturer prepares 750 kg of refrigerated cargo for a European buyer.

The product must remain between 2°C and 8°C.

The manufacturer’s QA team approves the batch and transport condition.

The cargo is placed in qualified packaging.

The packaging system is validated for 96 hours.

The expected complete movement from manufacturing pickup to consignee handover is 58 hours.

This gives approximately 38 hours of additional qualified duration.

The refrigerated vehicle collects the shipment from the manufacturing unit.

The cargo reaches Hyderabad Airport according to the planned customs and airline timeline.

Customs clearance is completed, and the cargo remains under appropriate airport handling.

The flight is delayed by 6 hours.

The shipment is now expected to complete in approximately 64 hours.

The packaging still has around 32 hours of qualified duration available.

This type of margin is valuable because it allows routine disruption to be absorbed without immediately creating a quality emergency.

The example demonstrates why packaging duration should include contingency rather than match the planned schedule exactly.

2. 15°C to 25°C Shipment to the USA

An Indian pharmaceutical manufacturer exports 500 kg of finished formulations to the United States.

The product requires 15°C to 25°C conditions.

Because the shipment does not require 2°C to 8°C refrigeration, the commercial team initially treats it like standard air cargo.

The logistics team identifies the risk.

The shipment is scheduled during a period when outside temperatures can exceed 35°C.

The cargo therefore still requires protection from uncontrolled heat.

Packaging is selected accordingly.

Pickup timing is planned to reduce unnecessary vehicle and airport dwell.

The airline route is evaluated according to transit handling.

The shipment moves through fewer uncontrolled points.

This scenario demonstrates an important principle.

15°C to 25°C is not the same as uncontrolled ambient transport.

Controlled room temperature cargo still needs a defined logistics plan.

3. Urgent Shipment from Delhi

A pharmaceutical company in Delhi needs to send 300 kg of finished medicines to an overseas distributor.

The distributor has only 5 days of inventory remaining.

Forwarder A offers an economical flight leaving after 2 days and requiring one international connection.

Forwarder B offers a faster route leaving the following day.

Forwarder B costs an additional ₹70,000.

The logistics manager could view ₹70,000 as an avoidable premium.

However, if the cheaper service creates a 2-day additional delay, the overseas buyer may run out of stock.

If the buyer’s daily sales of the product are ₹8 lakh, even one missed selling day creates a commercial impact much greater than ₹70,000.

The right decision is therefore based on the buyer’s inventory position and business impact rather than freight price alone.

Air Freight vs Sea Freight for Pharmaceutical Exports

Air freight is significantly more expensive than sea freight for most cargo.

That does not automatically mean sea freight is the better commercial option.

A stable pharmaceutical product with a long shelf life and large shipment volume may be suitable for sea freight.

For example, a 15-tonne shipment with no urgent delivery requirement may be far more economical by ocean freight.

Air freight is more attractive when cargo value is high, delivery is urgent, shelf life is limited or the buyer requires rapid replenishment.

Suppose sea freight costs ₹3 lakh while air freight costs ₹8 lakh.

The air freight premium is ₹5 lakh.

If sea freight takes 30 days longer and the buyer must hold ₹60 lakh of additional safety inventory, the commercial decision becomes more complex.

The exporter should consider working capital, product shelf life, buyer service requirements and disruption risk.

The correct mode should therefore be selected using:

• Product value
• Shelf life
• Urgency
• Total business cost

Sea freight remains relevant for suitable pharmaceutical cargo, but air freight becomes a strategic choice when the cost of time is high.

Role of a Pharmaceutical Freight Forwarder

A pharmaceutical freight forwarder should operate as a logistics coordinator rather than only an airline booking agent.

The process begins with shipment assessment.

The forwarder needs to understand product temperature, cargo weight, dimensions, packaging, origin, destination and required delivery date.

The next responsibility is route evaluation.

Direct and connecting airline options should be compared according to handling risk, schedule and cost.

The forwarder should understand whether the selected airport and airline can manage the required cargo conditions.

Pickup timing should then be coordinated with cargo readiness and airline cut-offs.

Documentation should be reviewed before customs filing.

Commercial Invoice, Packing List, Shipping Bill and AWB information should remain consistent.

The forwarder also coordinates customs, terminal handling and airline acceptance.

If the flight is delayed, the exporter needs useful information immediately.

A message saying “flight delayed” is not enough.

The logistics team needs to know:

How long is the delay?

Where is the cargo?

Is it still inside the correct temperature environment?

Does the packaging still have sufficient qualified duration?

What is the next flight option?

This is where pharmaceutical freight forwarding becomes an operational advisory function rather than simple shipment tracking.

How Pharma Exporters Can Reduce Air Freight Risk

The easiest way to reduce pharmaceutical freight risk is to identify failure points before cargo starts moving.

The first control is advance booking.

Last-minute booking reduces airline and route options.

A pharmaceutical exporter planning 2 to 4 weeks ahead usually has more flexibility than one searching for space the evening before cargo readiness.

The second control is realistic packaging duration.

A shipment expected to take 48 hours should not be planned with packaging that leaves no contingency.

The third control is route selection.

A route with 2 connections may save money but create additional handling events.

The fourth control is documentation.

Incorrect shipment data should be corrected at the manufacturing office, not at the airport cold room.

The fifth control is escalation planning.

The logistics team should know who needs to be contacted if the flight is delayed, customs asks for clarification or the temperature-monitoring system creates an alert.

A practical contingency plan should cover:

• Flight cancellation or rollover
• Customs or documentation delay
• Temperature alert
• Missed international connection

A shipment plan without an exception process is incomplete.

How Pharmaceutical Exporters Can Control Air Freight Cost

Air freight cost optimisation should not compromise product quality.

The best savings usually come from planning and packaging efficiency.

Chargeable weight is one major opportunity.

Suppose a pharmaceutical shipment weighs 400 kg but inefficient outer packaging creates a chargeable weight of 600 kg.

The exporter is effectively paying freight on 200 kg of additional volumetric weight.

At an illustrative ₹350 per kg, that difference creates ₹70,000 of unnecessary freight cost.

Packaging redesign may therefore reduce transport cost without reducing temperature protection.

Route planning also affects cost.

A direct flight may have higher airline freight but lower transit handling and lower packaging-duration requirements.

A connecting service may save on freight but require stronger packaging.

Airport dwell should also be controlled.

Using the earlier 1,500 kg example, 2 chargeable storage days at ₹5.08 per kg per day create approximately ₹15,240 in airport storage.

Ten similar avoidable incidents in a year would create approximately ₹1.52 lakh in airport storage costs alone.

This still excludes airline rebooking, refrigerated transport and packaging intervention.

Cost optimisation should therefore focus on:

• Chargeable weight
• Packaging efficiency
• Route selection
• Avoiding unnecessary dwell

How Cargo People Supports Pharmaceutical Exporters

Cargo People Logistics and Shipping Pvt. Ltd. supports Indian pharmaceutical manufacturers and exporters with international freight planning across air cargo, customs clearance, door-to-door delivery, warehousing, sea freight and project cargo.

For pharmaceutical air freight, planning begins with shipment details including cargo weight, dimensions, destination, required delivery date and approved transport conditions.

Airline routes can then be evaluated according to transit time, connection points and shipment requirements.

Cargo pickup can be coordinated from the manufacturer’s facility according to the logistics plan.

Export customs clearance support helps align Shipping Bill filing and commercial documentation with the booked flight.

For door-to-door shipments, logistics coordination can extend beyond the destination airport to final delivery according to the agreed scope.

Warehousing and distribution support can be used when exporters require cargo staging, consolidation or controlled dispatch planning.

Sea freight can also be evaluated for high-volume pharmaceutical cargo that is stable enough for longer transit and does not require urgent delivery.

Project cargo services can support pharmaceutical companies shipping production machinery, laboratory equipment, processing systems or oversized industrial equipment internationally.

The objective is not to offer the lowest per-kilogram freight number for every shipment.

The objective is to create a freight plan that balances delivery time, cargo risk, compliance and total logistics cost.

Final Decision Guide for Pharmaceutical Exporters

Pharmaceutical exporters should avoid applying one logistics formula to every product.

A 15°C to 25°C finished formulation with strong stability data may move safely through a well-managed connecting route.

A ₹1 crore 2°C to 8°C biological shipment may justify a more expensive direct flight and higher-grade packaging.

A frozen shipment may require specialised airport and airline capability.

An urgent medicine replenishment may justify premium air freight because the buyer cannot wait.

A 20-tonne stable pharmaceutical consignment with adequate shelf life may be more economical by sea freight.

The final logistics decision should consider 5 variables:

Product Stability + Temperature Requirement + Route Risk + Delivery Urgency + Total Logistics Cost

The lowest freight rate becomes irrelevant if the route creates unacceptable product or delivery risk.

Conclusion

Air Freight for Pharmaceutical Exports from India requires a much more controlled approach than ordinary international cargo because product quality, regulatory compliance, temperature integrity and customer delivery timelines are connected.

India’s pharmaceutical exports have crossed approximately US$31.11 billion, while finished formulations and biologicals represent more than 75% of pharmaceutical export value.

The United States alone accounts for approximately 34.51% of Indian pharmaceutical exports, making reliable international air logistics particularly important for manufacturers serving regulated global markets.

Official air cargo data shows that average export regulatory clearance at Indian Air Cargo Complexes can be approximately 3 hours 58 minutes, while refrigerated export cargo has recorded average cargo arrival-to-departure time of approximately 21 hours 38 minutes.

Hyderabad provides an important example of India’s growing pharma logistics capability, with pharmaceutical cargo accounting for approximately 72% of airport exports and new infrastructure providing up to 100,000 metric tonnes of expandable cargo capacity.

However, airport infrastructure alone cannot protect a pharmaceutical shipment.

The complete chain matters.

Factory pickup, packaging duration, customs documentation, airline acceptance, cold-room dwell, ramp transfer, international connection and destination delivery must work together.

For a ₹25 lakh shipment, saving ₹30,000 on a freight route may look attractive.

If that route creates an unacceptable temperature excursion, the commercial exposure can be several lakhs or even the complete cargo value.

This is why pharmaceutical exporters should evaluate logistics according to total risk-adjusted cost rather than the lowest freight rate.

For manufacturers, traders, procurement teams and supply chain managers, an experienced freight forwarding partner can help coordinate air freight, customs clearance, door-to-door delivery, warehousing and alternative shipping modes under one operational plan.

📞 +91 97174 65454
📧 wecare@cargopeople.com

👉 Get a Shipping Quote from Cargo People Logistics

Frequently Asked Questions

1. What temperature is required for pharmaceutical air freight?

The required temperature depends on the product specification. Common ranges include 15°C to 25°C, 2°C to 8°C, around -20°C and specialised deep-frozen conditions, but the manufacturer’s approved transport requirement should always determine the handling plan.

2. How long does pharmaceutical air freight from India take?

Many international pharma air shipments can complete within a few days, but total door-to-door time depends on pickup, customs clearance, airport dwell, direct or connecting flights and destination delivery.

3. How long does export customs clearance take at Indian airports?

Average export regulatory clearance at Air Cargo Complexes has been approximately 3 hours 58 minutes, although individual pharmaceutical shipments can take longer where additional assessment, examination or documentation is required.

4. What documents are required for pharmaceutical exports from India?

Core documents normally include the Commercial Invoice, Packing List, Shipping Bill and Airway Bill. Additional regulatory documents, licences, certificates or quality records depend on the product and destination.

5. Is a direct flight better for pharmaceutical cargo?

Direct flights reduce handling points and connection risk, which can be valuable for high-value and temperature-sensitive cargo. Connecting services may still be suitable where strong pharma handling and adequate contingency are available.